Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from Inotiv ( (NOTV) ) is now available.
On May 29, 2025, Inotiv, Inc. hosted its 2025 Investor Day, highlighting its strategic plans and addressing current challenges in the preclinical industry. The company discussed the potential impacts of US-imposed trade tariffs, proposed NIH funding cuts, and the FDA’s recent announcement to reduce animal testing. Inotiv emphasized its commitment to New Approach Methodologies (NAMs), which include computational toxicology and cell culture techniques, to support the development of safe therapies. These initiatives are expected to enhance Inotiv’s industry positioning and provide value to stakeholders by addressing evolving regulatory and market demands.
The most recent analyst rating on (NOTV) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Inotiv stock, see the NOTV Stock Forecast page.
Spark’s Take on NOTV Stock
According to Spark, TipRanks’ AI Analyst, NOTV is a Neutral.
The overall stock score is primarily impacted by poor financial performance, including high leverage and negative cash flows. While the earnings call provided some positive insights, the valuation remains unattractive due to a negative P/E ratio. Technical indicators show mixed signals, contributing to a cautious outlook.
To see Spark’s full report on NOTV stock, click here.
More about Inotiv
Inotiv, Inc. is a leading contract research organization (CRO) that provides drug discovery and development services primarily to the pharmaceutical and medical device industries. The company offers a comprehensive suite of high-quality research science, models, diets, and services, participating with clients in the discovery and development of novel therapeutics. Inotiv’s solutions span two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Founded in 1974 and reinvented in 2017, Inotiv is headquartered in West Lafayette, IN, with approximately 2,100 employees and around 2,200 clients.
Average Trading Volume: 720,264
Technical Sentiment Signal: Strong Sell
Current Market Cap: $87.6M
See more insights into NOTV stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue